Purification and characterization of a variant of human prothrombin: prothrombin Segovia
Collados MT, Fernández J, Páramo JA, Montes R, Borbolla JR, Montaño LF, Rocha E.
Laboratory of Vascular Biology and Thrombosis Research, School of Medicine, University of Navarra, Pamplona, Spain
Magazine: Thrombosis Research
Date: Mar 15, 1997Haematology and Hameotherapy
A dysprothrombin designated prothrombin Segovia was isolated from the plasma of an individual with normal prothrombin antigen and prothrombin activity lesser than 25% of the control prothrombin activity.
Activation by prothrombinase complex showed a lower amidolytic than clotting activity, which suggests a lesser generation of active intermediates than normal prothrombin. When prothrombin Segovia was activated by prothrombinase complex in the absence of factor Va, no thrombin formation was found by functional activities. SDS-PAGE analysis of the molecules derived by activation with prothrombinase complex, Taipan snake venom and Echis carinatus venom showed an accumulation of molecules not cleaved at bond Arg320-Ile321. This was more evident with Echis carinatus venom, which only acts on this bond.
Our data suggest that the alteration of prothrombin Segovia impairs the scission of bond Arg320-Ile321.
CITATION Thromb Res. 1997 Mar 15;85(6):465-77
you maybe interested
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.